NO20043717L - Dihydrotiaphenanthrene carbonyl guanidines, their method of preparation, their use as a drug or diagnostic - Google Patents

Dihydrotiaphenanthrene carbonyl guanidines, their method of preparation, their use as a drug or diagnostic

Info

Publication number
NO20043717L
NO20043717L NO20043717A NO20043717A NO20043717L NO 20043717 L NO20043717 L NO 20043717L NO 20043717 A NO20043717 A NO 20043717A NO 20043717 A NO20043717 A NO 20043717A NO 20043717 L NO20043717 L NO 20043717L
Authority
NO
Norway
Prior art keywords
dihydrotiaphenanthrene
diagnostic
drug
preparation
guanidines
Prior art date
Application number
NO20043717A
Other languages
Norwegian (no)
Inventor
Peter Below
Heinz-Werner Kleemann
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20043717L publication Critical patent/NO20043717L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/10—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20043717A 2002-02-07 2004-09-06 Dihydrotiaphenanthrene carbonyl guanidines, their method of preparation, their use as a drug or diagnostic NO20043717L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10204989A DE10204989A1 (en) 2002-02-07 2002-02-07 Dihydro-thia-phenanthren-carbonyl-guanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
PCT/EP2003/000653 WO2003066620A1 (en) 2002-02-07 2003-01-23 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent

Publications (1)

Publication Number Publication Date
NO20043717L true NO20043717L (en) 2004-11-03

Family

ID=27618378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043717A NO20043717L (en) 2002-02-07 2004-09-06 Dihydrotiaphenanthrene carbonyl guanidines, their method of preparation, their use as a drug or diagnostic

Country Status (25)

Country Link
EP (1) EP1474414B1 (en)
JP (1) JP4410564B2 (en)
KR (1) KR20040096555A (en)
CN (1) CN1319963C (en)
AR (1) AR038393A1 (en)
AT (1) ATE380805T1 (en)
AU (1) AU2003208337A1 (en)
BR (1) BR0307495A (en)
CA (1) CA2475093A1 (en)
CO (1) CO5601008A2 (en)
DE (2) DE10204989A1 (en)
HK (1) HK1073656A1 (en)
HR (1) HRP20040721A2 (en)
HU (1) HUP0402595A2 (en)
MA (1) MA27171A1 (en)
MX (1) MXPA04007476A (en)
NO (1) NO20043717L (en)
NZ (1) NZ534536A (en)
PE (1) PE20030963A1 (en)
PL (1) PL370271A1 (en)
RS (1) RS69204A (en)
RU (1) RU2306311C2 (en)
TW (1) TWI268927B (en)
WO (1) WO2003066620A1 (en)
ZA (1) ZA200406015B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200614995A (en) 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Tricyclic guanidine derivatives as sodium-proton exchange inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60262887A (en) * 1984-06-11 1985-12-26 Mitsubishi Chem Ind Ltd Liquid crystal composition
GB8505756D0 (en) * 1985-03-06 1985-04-11 Erba Farmitalia Tricyclic dibenzo condensed derivatives
US4948806A (en) * 1988-03-30 1990-08-14 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
DE19601303A1 (en) * 1996-01-16 1997-07-17 Boehringer Ingelheim Kg Novel benzoylguanidine derivatives, process for their preparation and their use in the manufacture of medicaments
AU4360200A (en) * 1999-04-23 2000-11-10 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
DE10001879A1 (en) * 2000-01-19 2001-07-19 Aventis Pharma Gmbh New benzoylguanidine derivatives are Na+/H+ exchange inhibitors useful for the treatment and prevention of e.g. ischemic disorders, infarction, arrhythmia, angina pectoris and stroke

Also Published As

Publication number Publication date
KR20040096555A (en) 2004-11-16
DE50308787D1 (en) 2008-01-24
CA2475093A1 (en) 2003-08-14
BR0307495A (en) 2004-12-28
ATE380805T1 (en) 2007-12-15
CN1630649A (en) 2005-06-22
PE20030963A1 (en) 2004-01-12
WO2003066620A1 (en) 2003-08-14
HK1073656A1 (en) 2005-10-14
RU2004126854A (en) 2006-01-27
RU2306311C2 (en) 2007-09-20
EP1474414B1 (en) 2007-12-12
TWI268927B (en) 2006-12-21
JP4410564B2 (en) 2010-02-03
DE10204989A1 (en) 2003-08-21
RS69204A (en) 2006-12-15
HRP20040721A2 (en) 2005-06-30
CO5601008A2 (en) 2006-01-31
EP1474414A1 (en) 2004-11-10
ZA200406015B (en) 2005-11-14
PL370271A1 (en) 2005-05-16
AU2003208337A1 (en) 2003-09-02
CN1319963C (en) 2007-06-06
MA27171A1 (en) 2005-01-03
HUP0402595A2 (en) 2005-04-28
NZ534536A (en) 2006-02-24
TW200404792A (en) 2004-04-01
AR038393A1 (en) 2005-01-12
MXPA04007476A (en) 2004-11-10
JP2005517015A (en) 2005-06-09

Similar Documents

Publication Publication Date Title
DK1592457T3 (en) FOLATE-VINBLASTIN CONJUGATE AS MEDICINAL
DK1549341T3 (en) Against tissue factor, antibodies directed as anticoagulants
DK3133070T3 (en) ELIGLUSTATE (GENZ 112638) AS A INHIBITOR OF GLUCOSYL CERAMIDE SYNTHESIS FOR USE IN A PROCEDURE FOR TREATING A FACTORY OR GAUCH'S DISEASE, WHICH METHOD OF METHODS INCLUDES THE ADMINISTRATION OF THE INDIVIDUAL
NO20054876D0 (en) Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as drug and drug containing such compounds
NO20040356L (en) Indanacetic acid derivatives and their use as pharmaceutical agents, intermediates and methods of preparation.
NO20054329D0 (en) Adamantan derivatives, processes for their preparation, and pharmaceutical compositions which include them
NO20054555D0 (en) Pharmaceutical preparations comprising acid stabilized insulin
NO20044322L (en) Benzoxanone-derived compounds, their preparation and use as a drug
NO20041785L (en) Pharmaceutical composition comprising mycophenolic acid or mycophenolate salt
DK1670458T3 (en) 1-Amino-2-oxy-substituted tetrahydronaphthalane derivatives, processes for their preparation and their use as antiphlogistics
DK1838315T3 (en) SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, METHOD OF PREPARING IT, THEIR USE AS MEDICINE AND MEDICINES CONTAINING THEM
DK1453810T3 (en) Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as a drug containing the same
DE602005014280D1 (en) PROCESS FOR THE PREPARATION OF Ä1,4,5Ü-OXADIAZEPINE DERIVATIVES
DK1513834T3 (en) Substituted thiophenes, methods for their preparation, their use as a drug or diagnostic, and drug containing them
NO20043717L (en) Dihydrotiaphenanthrene carbonyl guanidines, their method of preparation, their use as a drug or diagnostic
ITTO20030850A1 (en) PROCEDURE FOR THE PREPARATION OF 4-AMINO-3,5-DICLORO-BENZOTRIFLORURO.
ITMI20031994A1 (en) PROCEDURE FOR THE PREPARATION OF FLUDARABINA FOSFATO
DK1685096T3 (en) Pentafluorosulfanyl-benzoylguanidines, methods of their preparation, their use as a drug or diagnostic, as well as drugs containing them
ITMI20041920A1 (en) PROCESS FOR THE PREPARATION OF N, N-DIISOPROPYL-3-2-HYDROXY-5-METHYLPHENYL-3-PHENYL-PROPABAMMINE
DE602005013241D1 (en) PROCESS FOR THE PREPARATION OF CHINUCLIDINIUM CARBAMATE DERIVATIVES
NO20043009L (en) Substituted imidazolidines, their method of preparation, their use as a medicament or for diagnosis and medicament containing substituted imidazolidines
ITMI20030018A1 (en) PROCEDURE FOR THE PREPARATION OF SINGLE COMPOUNDS
IT1338456B1 (en) PROCEDURE FOR THE PREPARATION OF ALCHILUREE DA O, D-DIMETHYL DICIOCARBONATE
ITMI20052464A1 (en) PROCEDURE FOR THE PREPARATION OF NORELGESTROMIN NORELGESTROMINA
ITMI20040668A1 (en) PROCEDURE FOR THE PREPARATION OF A MULTICOLOR COLATO COSMETIC

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application